Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03819439 · ClinicalTrials.gov registry record
Microbiome and Mycobiome Registry of Volunteers With and Without Autism Spectrum Disorder
A clinical trial, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- 74
- Enrollment target
NCT03819439: Completed study, sponsored by University Hospitals Cleveland Medical Center.
NCT03819439 is a clinical trial that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 74 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03819439 has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- 74 participants
- Enrollment target
Study Summary
Analyze, describe, and understand how the human gut microbiome (i.e. bacteriome and mycobiome) and Autism Spectrum Disorder (ASD) are related.
Primary Outcome
Identifying relative abundance of individual bacterial and fungal members.
Interventions
- OTHER Microbiome and Autism Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2019-01-30 |
| Est. Completion | 2019-07-23 |
What the finished NCT03819439 record still lists
NCT03819439 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 74 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Microbiome and Autism Questionnaire is the first listed.
NCT03819439 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03819439 about?
NCT03819439 is a clinical study titled "Microbiome and Mycobiome Registry of Volunteers With and Without Autism Spectrum Disorder". Analyze, describe, and understand how the human gut microbiome (i.e. bacteriome and mycobiome) and Autism Spectrum Disorder (ASD) are related.
What is the current status of trial NCT03819439?
This trial is currently completed. The enrollment target is 74 participants. The study started on 2019-01-30. Estimated completion is 2019-07-23.
What interventions are being tested in trial NCT03819439?
The interventions under investigation include: Microbiome and Autism Questionnaire (OTHER).
Who is sponsoring clinical trial NCT03819439?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI